King Pharmaceuticals acquires Meridian Medical
Executive Summary
In all-cash deal, King Pharmaceuticals is buying auto-injector device developer Meridian Medical Technologies for $247.8mm. It is paying $44.50 per share, about a 22% premium to Meridian's average trading price.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice